Professor Jeremy Chapman is a renal physician with a special interest in transplantation. He is Clinical Director Division of Medicine and Cancer, Westmead Hospital and Director of Western Renal Services, Chair of the WSLHD Research Committee and Chairman of the Australian Bone Marrow Donor Registry, the Australian Cord Blood Bank Network and Past President of the Transplantation Society of Australia and New Zealand. He is Deputy Chair of the Board of Western Sydney Local Health District.
He is a Past-President of The Transplantation Society, Advisory Member of The World Health Organisation Expert Advisory Panel on Human Cell Tissue and Organ Transplantation, Secretary General and Past President of the World Marrow Donor Association and founding CoChair of the Declaration of Istanbul Custodian Group. He received the Asturias Foundation 2010 Award for International Cooperation on behalf of The Transplantation Society. He was awarded the 2010 David Hume Award of the US National Kidney Foundation. He was awarded Companion of the Order of Australia in 2015. He is the Editor-in-Chief for Transplantation and Transplantation Direct 2015-2020.
Professor Chapman’s clinical work is in renal medicine, transplantation of kidney and pancreas and diabetic renal disease and islet transplantation. Professor Chapman is actively involved in the academic field having over 400 publications. He is a Clinical Professor at the University of Sydney, a Fellow of the Royal College of Physicians in the United Kingdom and Fellow of the Royal Australasian College of Physicians
Dr Antonia Cronin is a Clinical Research Consultant Nephrologist at the NIHR Biomedical Research Centre, Guy’s and St Thomas’ NHS Foundation Trust, and MRC Centre for Transplantation, King’s College, London. She is a Trustee of the Governing Body of the Institute of Medical Ethics, and appointed member of the UK Donation Ethics Committee (UKDEC).
The main focus of her research is the ethical and legal analysis on matters raised by scientific research and clinical practice, in particular the regulation of research and its translation into clinical practice. Her work draws on interdisciplinary insights gained from science, medicine, social science, philosophical bioethics, public policy and the law.
Professor Delmonico is Professor of Surgery at Harvard Medical School at the Massachusetts General Hospital, where he is Emeritus Director of Renal Transplantation. He is also Medical Director of the New England Organ Bank, and Past President of the United Network for Organ Sharing, the federally designated Organ Procurement Transplant Network (OPTN) that oversees the practice of transplantation in the United States. He is also Past President of The Transplantation Society, an Advisor to the World Health Organization in matters of organ donation and transplantation, Senior Advisor to the Declaration of Istanbul Custodian Group, and a member of the Pontifical Academy of Sciences.
Professor Delmonico is renowned for his work in combatting organ trafficking and transplant “tourism”, and supporting the development of ethical practice in donation and transplantation throughout the world. He has authored or co-authored more than 300 publications, including in the New England Journal of Medicine, Lancet, the Journal of the American Medical Association and the New York Times. He is a former Board member of the National Kidney Foundation (NKF) and a recipient of the NKF’s David M. Hume Lifetime Achievement Award. He was a co-recipient of the Prince of Asturias award on behalf of The Transplantation Society in 2010 for his efforts in the establishment of the Declaration of Istanbul. He has received the Shumakov Medal from the Moscow Institute of Transplantation and the Gold Medal of the Catalan Transplantation Society. He has received Honorary Doctorates from the Pan American University of Mexico City, Salem State University, and the Karolinska Institute.
Dr Ian Dittmer is a Renal Physician specializing in transplantation. He trained in Auckland, New Zealand and Bristol, UK with a special interest in clinical immunology. He has overseen the NZ kidney allocation scheme since 1998.
Dr Dittmer is an active clinical transplant physician and is head of the Department of Renal Medicine at Auckland City Hospital. He is also a member of the Declaration of Istanbul Custodial Group and the TTS Ethics Committee. In 2015, he completed a sabbatical focusing on the ethics of live donor transplantation especially the issue of the balance between patient autonomy and professional protectionism (paternalism).
Professor Karen Dwyer is a clinician researcher with her clinical and research expertise being in the study of acute and chronic kidney disease and kidney transplantation. She oversees basic science studies using mouse models of acute and chronic kidney disease which she established. This is on top of clinical practice and the recent appointment to the School of Medicine at Deakin University. Karen is known for her energy and innovation. She is becoming a role model to up and coming clinicians and has supervised a number of junior nephrologists to a higher degree. She is a champion for women in science and medicine and has mentored a number of women both in clinical medicine and research.
Karen has published over 70 papers. She has received a number of awards including the prestigious Ian McKenzie Prize for Outstanding Contribution to Transplantation. Her supervision has been acknowledged with the Basic Science Mentor-Mentee Award on two occasions through the International Transplant Society. Karen has been invited to present her work at a number of conferences highlighting her standing in both the national and international communities. Clinically Karen was the lead physician in Australia’s First hand Transplant Procedure, which was recognised in the Premier’s Health Awards. She has been a strong contributor to the growth of the rural outreach nephrology service in South West Victoria.
Outside of medicine, Karen is a mother to 4 children (3-13yo). She enjoys keeping fit and has completed 6 marathons.
Dr Marisa Herson, MD, PhD, is an Honorary Associate Professor in Health Ethics and Professionalism at Deakin University and Adjunct Senior Lecturer in Surgery at Monash University, Melbourne.
Dr Herson graduated in Medicine in Brazil and trained in General and Plastic Surgery (Burn Care) in Israel. Upon returning to Brazil, the clinical and surgical care of burn victims evolved to further research into wound healing models and skin substitution. Progressive engagement with tissue donation and transplantation lead to the implementation and management of the Skin Tissue Bank at the Hospital das Clinicas. She moved to Australia in 2007 to head the Donor Tissue Bank of Victoria, in Melbourne. She left the position in 2011 to join the Adult Victorian Burns Unit – Skin Cell Culture Laboratory where she worked in translational research and contributed in the implementation in the manufacturing environment to support clinical trials in skin substitution.
She is the General Secretary of the World Union of Tissue Banking Associations (WUTBA), and has contributed to the field of tissue donation, banking and transplantation with numerous scientific publications, teaching engagements and provision of expert advice to national and international regulatory and policy making bodies.
Dr Dominique Martin, MBBS, BA, PhD, is Senior Lecturer in Health Ethics and Professionalism in the School of Medicine at Deakin University. Much of her research focuses on ethical issues relating to the procurement, distribution, and use of medical products of human origin, such as organs and tissues for transplantation.
Dr Martin is co-chair of the Declaration of Istanbul Custodian Group, and past co-chair of the Ethics Committee of the Transplantation Society. She has previously worked in collaboration with the World Health Organization and the Australian Organ and Tissue Authority on ethical issues in donation and transplantation, and is a member of the Doha International Academy of Organ Donation. She has authored or co-authored more than 35 peer reviewed journal articles and book chapters, and regularly presents at international conferences.
Professor Muller is a groundbreaking general surgeon who has worked in transplantation since 2005. In 2008 she became the first surgeon to perform kidney transplants in HIV positive patients utilizing HIV positive donors at Groote Schuur Hospital in Cape Town, South Africa. She has an active interest in promoting organ donation and transplantation in developing countries, and supporting ethical policy and practice in transplantation around the world. She has received several awards including CEO Magazine’s Most Influential Woman in Business and Government: Africa award (2014), and The Transplantation Society’s Women In Transplantation Hero award (2016).
Professor Muller currently serves as Co-Chair of the Declaration of Istanbul Custodian Group, and as a member of the Executive Council of The Transplantation Society. She is past president of the South African Transplantation Society. She is Head of the Transplant Unit and the Division of General Surgery at the Groote Schuur Hospital, and Professor of Surgery at the University of Cape Town.
Dr Helen Opdam is the National Medical Director of the Australian Organ and Tissue Authority and DonateLife Network. She is a Senior Intensive Care Specialist at the Austin Hospital in Melbourne.
Helen has been involved in organ donation since 1998, initially in developing an audit to determine the hospital potential for organ donation. She was the inaugural Victorian State Medical Director for DonateLife when the National Reform of donation began in 2009.
She contributes to numerous committees and working groups including being a Council member of the International Society for Organ Donation and Procurement, and is a regular invited speaker at national and international conferences.
Dr Opdam graduated in medicine from Monash University in 1990 with First Class Honours.
Director of Lions Eye Donation Service Melbourne, Graeme holds joint appointments with the Centre for Eye Research Australia and The University of Melbourne. He is currently the chair of the Eye Bank Association of Australia and New Zealand (EBAANZ) and founding member and co-chair of the Global Alliance of Eye Bank Associations (GAEBA).
Graeme has spent the past 25 years involved in eye banking at local, national and international levels. More recently he has been involved in the development and establishment of the EBAANZ Bioethical Framework, and, together with his work-colleagues, is currently participating in the development and drafting of a global bioethical framework for eye banking through GAEBA and world-wide eye bank representatives.
Ms Ann Smith is Senior Executive Commonwealth Health Department and immediate past Chief Executive Officer (acting), Organ and Tissue Authority.
Ms Smith led the Organ and Tissue Authority (OTA) over 6 months in 2017. In that time the new OTA Board was established, a new simplified Organ Donation online registration form was developed and released, the 2017 DonateLife week was held and partnerships were established for the first time with major sporting bodies including the AFL and NRL to promote organ donation awareness.
Prior to the OTA, Ms Smith worked with the Health Department for 6 years. During that time Ms Smith held senior executive roles leading policy and program work in a wide range of acute hospital areas, a $5 billion health infrastructure investment as well as a People Branch corporate role for the 5,000 staff in Health.
In the Public Service, Ms Smith has worked at the Senior Executive level for the Fair Work Ombudsman, the then Department of Employment and Workplace Relations and the Family Court of Australia. Ms Smith was responsible for a range of outcomes that focused on both policy and services delivery in these organisations.
Prior to the Public Service, Ms Smith was Executive Director for two private hospitals in Melbourne. These roles followed her work in Health in education, quality management and nursing – primarily in Intensive Care. It was here that Ms Smith first gained experience with families of organ donors as well as those who had received transplants.
Ms Smith is an ANZSOG Fellow and holds a Master in Business Administration (International Management) and a Graduate Diploma in Adult Education and Training
Associate Professor Allison Tong is a Principal Research Fellow at the Sydney School of Public Health, The University of Sydney. She holds an Australian National Health and Medical Research Council (NHMRC) Career Development Fellowship. She is a social scientist and has experience in using applied qualitative research methods to the area of chronic disease; to inform practice and policy for improved patient-centred outcomes.
Her current research projects examine psychosocial aspects, outcomes, and ethics in living kidney donation. Allison also has a particular interest and experience in stakeholder engagement (including patients and consumers) in the context of research priority setting and the development of core outcomes for research.
She co-founded and is on the Executive Committee of the global Standardised Outcomes in Nephrology (SONG) Initiative, which aims to establish consensus-based core outcomes across the spectrum of chronic kidney disease (www.songinitiative.org).
Joyleen’s involvement in tissue banking began 18 years ago when she commenced as the Quality Manager position at PlusLife (Perth Bone & Tissue Bank), a musculoskeletal tissue bank located in Perth Western Australia. Following this, she became an active member of the Australasian Tissue Banking Forum (now BAA), which developed tissue banking guidance standards and systems for risk management and surveillance of infectious epidemiological situations.
Having participated in the consultation process for the development of the Regulatory framework for Biologicals including the relevant Therapeutic Goods Orders, Joyleen also served on the Therapeutic Goods Committee for two years. She continues to be involved in the ongoing development our regulatory system. Joyleen is also the current President of the Biotherapeutics Association of Australasia (BAA); the peak industry body for tissues and biotherapeutics in Australia. BAA aims to ensure that high quality and ethically sourced human biotherapeutic products are consistently available to meet needs, thereby achieving the best possible outcomes for recipients.
Joyleen is also actively involved in representing the interests of tissue banking on a range of OTA committees and working groups.